Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial

Table 3

Comparison of Expanded Disability Status Scale (EDSS) and relapses in 50 patients with relapsing-remitting multiple sclerosis after 12 months of treatment with low-dose vitamin D and placebo.

	Treatment group		Differences (95% CI)
	Vitamin D (𝑛=25) Mean (SD)	Placebo (𝑛=25) Mean (SD)
EDSS at 12-months	1.63 (0.70)	1.94 (1.41)	−0.31 (−0.94, 0.32)
Relapses at 12-months	0.32 (0.48)	0.40 (0.58)	−0.08 (−0.38, 0.22)